Belaperidone

This classification denotes an antipsychotic agent with the molecular formula C22H22FN3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4DN0TK4892, chemically known as 2,4(1h,3h)-quinazolinedione, 3-(2-((1s,5r,6s)-6-(4-fluorophenyl)-3-azabicyclo(3.2.0)hept-3-yl)ethyl)- but generally known as belaperidone, which bears US NIH Compound Identifier 184841. European Medicines Agency schedules Belaperidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05685MIG. The term BELAPERIDONE is an International Non-Proprietary Name. BELAPERIDONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule belaperidone under HS 29335995 and SITC 51576. As of Q4 2014, BELAPERIDONE remains the US FDA Preferred Term for this commodity. Belaperidone bears US NLM identifiers UMLS ID C2698342 and NCI Concept Code C78794. SMILES: FC1CCC(C2C3C(C2)CN(C3)CCN2C(=O)C3C([NH]C2=O)CCCC3)CC1.